Fulcrum Pharma History

Fulcrum Pharma was established as a privately held company in the UK in 1999 by the management team of Protodigm Ltd, a virtual drug development team created within Hoffmann La Roche. In March 2000, Fulcrum became a publicly traded company listed on the London Stock Exchange Alternative Investment Market.

Fulcrum has grown through acquisition of two leading European regulatory businesses—QuadraMed in 2006 and Unicus Regulatory Services in 2007.

1999   Fulcrum Pharma was founded with headquarters in the United Kingdom

2000   Established operations in Japan

2000   Listed on the Alternative Investment Market (London)

2002   Established operations in the US

2002   Expanded Japanese operations by establishment of Niphix, a specialty oncology CRO

2006   Expanded regulatory services with the acquisition of QuadraMed

2007   Expanded regulatory and pharmacovigilance services with the acquisition of Unicus